“Harmony: The Saga of the Earth” – A Poetic Journey into Nature’s Heart by Apala Banerjee

"Harmony: The Saga of the Earth" - A Poetic Journey into Nature’s Heart by Apala Banerjee
“Harmony: The Saga of the Earth” is a captivating anthology of 30 poems and illustrations that celebrates and raises awareness about nature’s beauty and its environmental challenges. Lauded by Literary Titan for its emotive imagery and profound connection between humanity and Earth, the collection emphasizes the importance of nature’s preservation for future generations.

The world of literature welcomes a refreshing and profound voice in the form of 14-year-old poet Apala Banerjee, with her latest publication, “Harmony: The Saga of the Earth.” This collection of 30 poems, complemented by evocative illustrations, is a testament to Banerjee’s love for nature and her concern for its preservation.

From the mind of a 10th grader who finds solace in reading, playing the violin, and kitchen gardening, this anthology emerges as a vibrant tribute to the natural world. Apala, a young but already twice-published author, captures the essence of the environment’s beauty and fragility through her words.

Literary Titan describes “Harmony: The Saga of the Earth” as “an elegantly crafted anthology, seamlessly weaving together poetry and art to explore and celebrate the natural world.” The review praises Banerjee’s ability to depict “nature’s grandeur and vulnerabilities” and highlights the anthology as “a tapestry of emotive and vivid imagery.”

In an interview with Literary Titan, Banerjee expressed her intent behind the collection: “I wanted to share the beauty and gifts that Nature has to give. I also wanted to emphasize the importance of preservation for future generations.” She hopes readers will recognize the need to cherish and protect the natural world, making it an everyday habit. Recalling her childhood experiences in Central Park, Banerjee shares how these moments deepened her connection with nature and inspired her writings.

“Harmony: The Saga of the Earth” has been honored with the prestigious Literary Titan Gold Book Award, further cementing Apala Banerjee’s status as a significant new voice in literature. This award highlights Banerjee’s exceptional ability to intertwine poetry and environmental awareness.

“Harmony: The Saga of the Earth” is an invitation to pause, reflect, and appreciate the wonders of our planet. Banerjee’s work is a call to action, urging us to acknowledge and address the environmental challenges we face.

Apala Banerjee’s collection is available on Kindle and in paperback on Amazon. Readers are invited to embark on this poetic journey, to rediscover the enchantment of the outdoors, and to join the conversation about preserving our planet for future generations.

About the Book

In the heart-stirring pages of “Harmony: The Saga of the Earth,” a young poet with an old soul, weaves a tapestry of vivid poetry that captures the raw beauty and whispered secrets of nature. Each line, infused with the passion of her youthful spirit and the wisdom of a seasoned guardian of the earth, beckons readers into a world where every rustling leaf and blooming flower tells a story of wonder, resilience, and an urgent plea for preservation. Journey through the seasons of the soul and awaken your senses to the fragile splendor of our planet. This book is a poignant reminder of the delicate balance that we, as stewards of the earth, must uphold. The author’s words, both powerful and tender, resonate with a truth that stirs the heart, urging us to look beyond ourselves and embrace the profound connection we share with the natural world.

About the Author

Apala Banerjee is a 14-year-old poet and student who juggles her love for literature with her passion for the violin and kitchen gardening. With “Harmony: The Saga of the Earth,” she continues to establish her presence in the literary world following her debut publication. Her work stands as a beacon of inspiration for young and adult readers alike, demonstrating the profound impact of young voices on critical global issues.

Media Contact
Company Name: Literary Titan
Contact Person: Apala Banerjee
Email: Send Email
Country: United States
Website: https://amzn.to/3HD2Oyq

4SC AG’s Resminostat market size expected to increase many folds by 2032, report DelveInsight

“Resminostat Drug Market Forecast and Analysis”
Resminostat Market Size, Forecast, and Emerging Insight 2032 report provides comprehensive insights about Resminostat for Cutaneous T-cell lymphoma in the seven major markets. A detailed picture of the Resminostat for Cutaneous T-cell lymphoma in the 7MM, i.e., the United States, EU4 (Germany, France, Italy and Spain) and the United Kingdom, and Japan for the study period 2019–2032 is provided in this report along with a detailed description of the Resminostat for Cutaneous T-cell lymphoma.

DelveInsight has recently published a report on “Resminostat Market Forecast Report” providing an in-depth analysis of the Resminostat market analysis and forecasts up to 2032 in the seven major markets (7MM) (i.e. the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The comprehensive report provides an analysis of Resminostat market potential and market share analysis in the Cutaneous T-cell lymphoma therapeutics space across the 7MM from 2019 to 2032. 

The report also helps you to understand the Resminostat clinical and commercial developments along with parameters like the drug’s Mechanism of Action (MOA), Route of Administration (ROA), dosage, and special designations.

Interested in finding out the projected market size of Resminostat by 2032? Visit:Resminostat Market Forecast

Resminostat Drug Summary

Resminostat is a potent inhibitor of class I, IIb, and IV HDACs, including a pronounced activity against HDAC6. In pharmacology studies, resminostat dose-dependently inhibited HDACs and induced acetylation of histone and non-histone proteins, resulting in changes in gene expression levels in tumor cells and the deregulation of pathways involved in cell differentiation, such as WNT signaling. Changes in cell differentiation are very often the cause of tumor progression, metastasis, and acquired resistance to anti-cancer treatment. Resminostat is currently being investigated in a pivotal study in cutaneous T-cell lymphoma (CTCL) as a maintenance treatment by 4SC in Europe and by Yakult Honsha in Japan.

Resminostat has demonstrated effects in CTCL-derived cell lines, stabilizing less advanced malignantly transformed T cells or even reversing advanced stages of disease to less advanced stages, which indicates a unique potential in both maintenance therapy as well as in the treatment of progressive disease.

In addition to these important effects on the differentiation of tumor cells, resminostat also increases the immunogenicity of tumors by enhancing natural killer (NK) cell recognition and killing, increasing expression and presentation of tumor-associated antigens (that support T-cell functions), and reducing unspecific immunosuppressive mechanisms.

In vivo, resminostat has demonstrated significant anti-tumor activity in various human xenograft mice tumor models, and in combination with established therapies—such as irinotecan or sorafenib – generated additive, synergistic anti-tumor effects.

In January 2023, 4SC AG announced that its pre-authorization eligibility request to the European Medicines Agency (EMA) for resminostat in cutaneous T-cell lymphoma had been accepted. 

Stay ahead of the competition by leveraging key insights and evolving trends in the Resminostat Market @ Resminostat Market Outlook and Key Assessment

Key Highlights of the Resminostat Market Report

  • The report contains forecasted sales evaluation of Resminostat for Cutaneous T-cell lymphoma till 2032.
  • It provides comprehensive coverage of late-stage emerging therapies for Cutaneous T-cell lymphoma treatment.
  • The report also features qualitative and quantitative analysis with analysts, as well as KOL views for Resminostat in Cutaneous T-cell lymphoma.

Why Resminostat Market Report?

  • Leading Resminostat for Cutaneous T-cell lymphoma forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the Resminostat.
  • A thorough Resminostat market forecast will help understand how the drug is competing with other emerging therapies in the therapeutics landscape.
  • It will help to get an analysis of the Resminostat clinical trial advancements and the detailed clinical assessment, regulatory, and commercial assessment
  • The report also provides future market assessments for Resminostat market for Cutaneous T-cell lymphoma in the 7 Major Markets, advanced qualitative analysis like SWOT, expert analysts’ views, a detailed overview of market competitors, and a short analysis of other emerging therapies in Cutaneous T-cell lymphoma.

Download the sample report to learn more about the evolving market dynamics @ Resminostat Market Trends and Key Developments

Related Reports By DelveInsight:

Cutaneous T-cell lymphoma Market Outlook and Forecast

“Cutaneous T-cell lymphoma Market Insights, Epidemiology and Market Forecast 2032” report delivers an in-depth understanding of Cutaneous T-cell lymphoma, historical and forecasted epidemiology as well as the Cutaneous T-cell lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France), and the United Kingdom, and Japan. It also covers the key companies and emerging therapies in the Cutaneous T-cell lymphoma therapeutics landscape.

Top Services Offered By DelveInsight:

Explore success with our case study on R&D, Manufacturing & Commercial Capabilities. Uncover insights for strategic growth in the industry.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/case-study/r-and-d-landscape-assessment

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: 4SC AG’s Resminostat market size expected to increase many folds by 2032, report DelveInsight

Hestia Agency Unveils Innovative Digital Marketing Solutions to Elevate Brands’ Online Presence

Hestia Agency provides a variety of state-of-the-art solutions targeted at improving brands’ online visibility

Hestia Agency

California – February 5, 2024 – In a significant leap towards digital excellence, Hestia Agency proudly announces the launch of its revamped website, marking a new chapter in its journey as a leading innovator in the digital landscape. The agency’s commitment to delivering measurable results and enhancing brand recognition is evident in this substantial upgrade.

Born from a passion for digital innovation, Hestia Agency has evolved from a humble startup to a prominent player in the digital marketing arena. The new website serves as a testament to the agency’s growth and commitment to staying at the forefront of digital trends.

“Digital marketing is an ever-evolving landscape, and at Hestia Agency, we are committed to staying at the forefront of innovation,” said Adrian Gheorghe, Founder and CEO of Hestia Agency. “Our mission is to craft marketing strategies that not only resonate with our clients’ target audience but also deliver tangible results that impact their bottom line.” 

As an innovative digital agency, Hestia Agency specializes in providing cutting-edge digital marketing solutions that prioritize integrity, simplicity, transparency, and performance. With a portfolio boasting over 1,500 successful cases, the agency has firmly established itself as a go-to destination for businesses seeking impactful digital strategies.

Hestia Agency’s team comprises creative thinkers, digital strategists, and marketing mavens who possess a deep understanding of the industry and a passion for driving success. With a focus on innovation, integrity, and impact, they work closely with clients to develop tailored marketing solutions that align with their unique goals and objectives. 

The new website showcases Hestia Agency’s extensive range of digital marketing services, including search engine optimization, website design, paid advertising, email marketing, and video and graphic design. These solutions are designed to help businesses filter their customers, increase profitability, and maximize their reach in the digital landscape. 

The website launch coincides with Hestia Agency’s relentless focus on integrity, simplicity, and transparency, values that are embedded in the core of its operations. The revamped site not only showcases the agency’s rich history and successful cases but also introduces its dynamic team of creative thinkers, digital strategists, and marketing mavens. 

Hestia Agency’s mission is clear: to craft marketing strategies that not only resonate with audiences but also deliver tangible and measurable results. The agency’s vision for the future revolves around continued innovation, unwavering integrity, and creating a lasting impact in the digital realm. 

For more information on Hestia Agency’s innovative digital solutions or to explore their success stories, visit https://hestiagency.net/. Stay connected with Hestia Agency on LinkedIn, Instagram, Facebook, and YouTube for the latest updates and insights.

About Hestia Agency:  

Hestia Agency’s newly upgraded website is a testament to their commitment to excellence in digital marketing. With a sleek and user-friendly interface, the website showcases their range of cutting-edge solutions aimed at promoting and elevating brands’ online presence. From search engine optimization to website design, paid advertising to email marketing, Hestia Agency offers a comprehensive suite of services that deliver measurable results. With a focus on innovation, integrity, and impact, their team of experts is poised to help businesses thrive in the competitive digital landscape.  

Media Contact
Company Name: Hestia Agency
Contact Person: Adrian Gheorghe
Email: Send Email
Phone: +40753671308
Address:Aleea Pantelimon, nr. 4
City: Bucharest
Country: Romania
Website: https://hestiagency.net/

New Fashion Clothing for Traveling with Comfort: Cool Trends Introduces Trending Collection for 2024

Cool Trends offers a diverse range of trendy apparel made from durable travelstof fabric.

Travelstof Fashion

California – February 5, 2024 – Cool Trends, a leading online retailer of travel-friendly clothing, is excited to announce its latest collection of fashion clothes designed for travelers seeking comfort and style. The brand’s website offers a wide range of trendy and high-quality apparel made from travelstof fabric, perfect for those on the go. 

The fabric used in Cool Trends Fashion’s clothing is known for its durability, breathability, and quick-drying properties. It provides the perfect blend of comfort and functionality, making it ideal for long journeys, outdoor adventures, or simply everyday wear. With Cool Trends, travelers no longer have to compromise between style and comfort.

“We believe that everyone deserves to wear comfortable clothing while feeling beautiful and confident,” said J. Shir, spokesperson for Cool Trends. “Our collection is designed to provide a sense of comfort and style, allowing travelers to look and feel their best wherever they go.”

In addition to its commitment to comfort, Cool Trends also emphasizes sustainability. By shipping products directly from the supplier, the brand reduces transportation, storage, and packaging materials, contributing to a more eco-friendly approach. This allows Cool Trends to offer its products at a fair price while promoting a greener future.

Customers can enjoy the convenience of online shopping with Cool Trends. The website features a user-friendly interface and offers a wide range of categories to choose from, including Travelstof Broek, jumpsuits, blazzers, rokken, Travelstof Kleding, Mi Piace, and more. With a focus on trendy and popular products, Cool Trends ensures that its customers stay fashionable while traveling in 2024 and beyond.

The customer experience is a priority for Cool Trends. The brand’s commitment to providing first-class service is evident in its dedication to helping customers. Whether customers have questions about product details, sizing, or any other inquiries, the brand’s customer service team is available to assist them.

Overall, Cool Trends offers a convenient and stylish shopping experience for travelers and fashion enthusiasts alike. With their focus on comfort, sustainability, and trendy designs, the brand continues to be a go-to destination for those seeking fashion-forward clothing for their travels.

For more information and to explore the latest collection, please visit travelstoffashion.nl

About Cool Trends:  

Cool Trends is a one-stop destination for fashion-forward individuals seeking comfortable and stylish clothing for their travels. With a wide range of categories, including pants, dresses, jackets, and more, the website offers a diverse selection of trendy and high-quality garments made from travelstof fabric. With a focus on sustainability and providing excellent customer service, Cool Trends ensures a seamless and enjoyable shopping experience for fashion-conscious travelers.

Media Contact
Company Name: Travelstof Fashion
Contact Person: J. Shir
Email: Send Email
Country: Netherlands
Website: https://travelstoffashion.nl/

Canadian Model Keyara Nelson is Crowned Miss Nation Universe 2024

In the glittering world of pageantry, Keyara Nelson stands out as a beacon of grace, talent, and perseverance. Hailing from the vibrant country of Canada, Keyara Nelson’s ascent to the prestigious title of Miss Nation Universe 2024 was not just a coronation but a testament to her unwavering dedication and remarkable journey.

Born with a vision and determination, Keyara’s passion for modeling ignited at a young age. Her dreams soared high against the backdrop of the Canadian landscape, where she nurtured her aspirations with grit and resilience. As she honed her skills and carved her path in the competitive realm of fashion, Keyara Nelson emerged as a promising talent, captivating hearts with her elegance and charisma.

Photo Credits to: Frank Bokehlicious

The crowning moment for Keyara came on November 12, 2023, in the enchanting city of Tampa, Florida. Amidst a symphony of cheers and applause, she was bestowed with the coveted title of Miss Nation Universe 2024, a pinnacle of achievement that marked her hard work and dedication.

Keyara’s journey to the crown was a journey of self-discovery and empowerment. Being at first a shy girl, pageantry has helped the 20 year old to embrace her uniqueness, celebrating diversity and breaking barriers that transcended the confines of conventional beauty standards. With each stride down the runway, she instills a sense of confidence and courage.

Keyara’s reign as Miss Nation Universe 2024 symbolizes not just a moment in time but a legacy of empowerment and advocacy. Beyond the glitz and glamour, she endeavors to use her platform to amplify voices, champion causes, and make a meaningful impact on society. Whether advocating for, promoting mental health awareness, or supporting humanitarian initiatives, Keyara Nelson embodies the essence of beauty with a purpose.

Photo Credits to: Frank Bokehlicious

As she continues to grace stages and illuminate the world with her presence, Keyara Nelson remains a beacon of hope and inspiration for generations to come. Her journey from Canada to the pinnacle of international pageantry is a testament to the power of dreams, resilience, and unwavering determination.

In the kaleidoscope of life, Keyara Nelson’s story shines brightly, a testament to the indomitable spirit that dares to dream and dares to soar. As she carries the crown of Miss Nation Universe 2024, her legacy resonates far and wide, igniting the flames of possibility and inspiring hearts to believe that with passion and perseverance, anything is possible.

Support Keyara and follow her on Instagram @keyara_nyasha

Photo Credits: Frank Bokehlicious (Instagram: @frankbokehlicious)

Media Contact
Company Name: Miss US Nation Pageants
Contact Person: Media Relations
Email: Send Email
Phone: (954) 274-5600
Country: United States
Website: www.missusnationpageants.com

Servier’s TIBSOVO market size expected to increase many folds by 2032, report DelveInsight

“TIBSOVO Drug Market Forecast and Analysis”
“TIBSOVO Market Size, Forecast, and Drug Insight – 2032” report provides comprehensive insights about TIBSOVO for Cholangiocarcinoma (CCA) in the seven major markets. A detailed picture of the TIBSOVO for Cholangiocarcinoma in the 7MM, i.e., the United States, EU4 (Germany, France, Italy and Spain) and the United Kingdom, and Japan for the study period 2019–2032 is provided in this report along with a detailed description of the TIBSOVO for Cholangiocarcinoma.

DelveInsight has recently published a report on “TIBSOVO Market Forecast Report” providing an in-depth analysis of the TIBSOVO market analysis and forecasts up to 2032 in the seven major markets (7MM) (i.e. the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The comprehensive report provides an analysis of TIBSOVO market potential and market share analysis in the Cholangiocarcinoma therapeutics space across the 7MM from 2019 to 2032. 

The report also helps you to understand the TIBSOVO clinical and commercial developments along with parameters like the drug’s Mechanism of Action (MOA), Route of Administration (ROA), dosage, and special designations.

Interested in finding out the projected market size of TIBSOVO by 2032? Visit:TIBSOVO Market Forecast

TIBSOVO Drug Summary

TIBSOVO (Ivosidenib) is a first-in-class isocitrate dehydrogenase-1 (IDH1) inhibitor. IDH1 is an enzyme that is often mutated and overexpressed in some cancers, leading to aberrant cell growth and proliferation. Ivosidenib inhibits mutated IDH1, blocking the enzymatic activity and further differentiation of cancer cells. It is approved for the treatment of adult patients with previously treated, locally advanced or metastatic cholangiocarcinoma with an isocitrate dehydrogenase-1 (IDH1) mutation.

Dosage and Administration

The recommended dose of TIBSOVO is 500 mg taken orally once daily until disease progression or unacceptable toxicity.

Mechanism of Action

TIBSOVO is a small molecule inhibitor that targets the mutant isocitrate dehydrogenase 1(IDH1) enzyme receptors.

Stay ahead of the competition by leveraging key insights and evolving trends in the TIBSOVO Market @ TIBSOVO Market Outlook and Key Assessment

Key Highlights of the TIBSOVO Market Report

  • The report contains forecasted sales evaluation of TIBSOVO for Cholangiocarcinoma till 2032.
  • It provides comprehensive coverage of late-stage emerging therapies for Cholangiocarcinoma treatment.
  • The report also features qualitative and quantitative analysis with analysts, as well as KOL views for TIBSOVO in Cholangiocarcinoma.

Why TIBSOVO Market Report?

  • Leading TIBSOVO for Cholangiocarcinoma forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the TIBSOVO.
  • A thorough TIBSOVO market forecast will help understand how the drug is competing with other emerging therapies in the therapeutics landscape.
  • It will help to get an analysis of the TIBSOVO clinical trial advancements and the detailed clinical assessment, regulatory, and commercial assessment
  • The report also provides future market assessments for TIBSOVO market for Cholangiocarcinoma in the 7 Major Markets, advanced qualitative analysis like SWOT, expert analysts’ views, a detailed overview of market competitors, and a short analysis of other emerging therapies in Cholangiocarcinoma.

Request the Sample PDF to Learn More About the Key Offerings of the Report @ https://www.delveinsight.com/sample-request/tibsovo-drug-insight-and-market-forecast

Related Reports By DelveInsight:

Cholangiocarcinoma Market Outlook and Forecast

“Cholangiocarcinoma Market Insights, Epidemiology and Market Forecast 2032” report delivers an in-depth understanding of Cholangiocarcinoma, historical and forecasted epidemiology as well as the Cholangiocarcinoma market trends in the United States, EU4 (Germany, Spain, Italy, and France), and the United Kingdom, and Japan. It also covers the key companies and emerging therapies in the Cholangiocarcinoma therapeutics landscape.

Top Services Offered By DelveInsight:

Elevate healthcare strategies with Delveinsight Healthcare Consulting. Unlock insights, navigate challenges, and drive success in the dynamic healthcare landscape.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Servier’s TIBSOVO market size expected to increase many folds by 2032, report DelveInsight

QED Therapeutics’ TRUSELTIQ market size expected to increase many folds by 2032, report DelveInsight

“TRUSELTIQ Drug Market Forecast and Analysis”
“TRUSELTIQ Market Size, Forecast, and Drug Insight – 2032” report provides comprehensive insights about TRUSELTIQ for Cholangiocarcinoma (CCA) in the seven major markets. A detailed picture of the TRUSELTIQ for Cholangiocarcinoma in the 7MM, i.e., the United States, EU4 (Germany, France, Italy and Spain) and the United Kingdom, and Japan for the study period 2019–2032 is provided in this report along with a detailed description of the TRUSELTIQ for Cholangiocarcinoma.

DelveInsight has recently published a report on “TRUSELTIQ Market Forecast Report” providing an in-depth analysis of the TRUSELTIQ market analysis and forecasts up to 2032 in the seven major markets (7MM) (i.e. the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The comprehensive report provides an analysis of TRUSELTIQ market potential and market share analysis in the Cholangiocarcinoma therapeutics space across the 7MM from 2019 to 2032. 

The report also helps you to understand the TRUSELTIQ clinical and commercial developments along with parameters like the drug’s Mechanism of Action (MOA), Route of Administration (ROA), dosage, and special designations.

Interested in finding out the projected market size of TRUSELTIQ by 2032? Visit:TRUSELTIQ Market Forecast

TRUSELTIQ Drug Summary

TRUSELTIQ (infigratinib) is an orally administered FGFR1-3 tyrosine kinase inhibitor in development for the treatment of patients with FGFR-driven diseases, including cholangiocarcinoma (bile duct cancer), urothelial carcinoma (bladder cancer), and achondroplasia. Infigratinib sparingly inhibits FGFR4; patients may tolerate it better than pan-FGFR1-4 inhibitors. QED Therapeutics holds worldwide rights to infigratinib to evaluate its safety and efficacy for multiple FGFR-driven diseases.

The company is also evaluating the product in a phase III clinical study for first-line therapy for cholangiocarcinoma (bile duct cancer) and in a phase II as second-line therapy for cholangiocarcinoma (bile duct cancer). It presented data on infigratinib in cholangiocarcinoma and urothelial carcinoma at the American Society of Clinical Oncology 2020 virtual scientific program.

Dosage and administration

The recommended dosage of TRUSELTIQ is 125 mg (one 100 mg capsule and one 25 mg capsule) taken orally once daily for 21 consecutive days followed by 7 days off therapy, in 28-day cycles. Continue treatment until disease progression or unacceptable toxicity

If a dose of TRUSELTIQ is missed by ≥4 hours or if vomiting occurs, instruct patients to resume the regular daily dose schedule for TRUSELTIQ the next day.

Mechanism of Action

Infigratinib is a small-molecule kinase inhibitor of FGFR with IC50 values of 1.1, 1, 2, and 61 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively. The major human metabolites of infigratinib, BHS697 and CQM157, have similar in vitro binding affinities for FGFR1, FGFR2, and FGFR3 compared to infigratinib. Infigratinib inhibited FGFR signaling and decreased cell proliferation in cancer cell lines with activating FGFR amplifications, mutations, or fusions. Constitutive FGFR signaling can support the proliferation and survival of malignant cells. Infigratinib had anti-tumor activity in mouse and rat xenograft models of human tumors with activating FGFR2 or FGFR3 alterations, including two patient-derived xenograft models of cholangiocarcinoma that expressed FGFR2-TTC28 or FGFR2-TRA2B fusions. Infigratinib demonstrated brain-to-plasma concentration ratios (based on AUC0-inf) of 0.682 in rats after a single oral dose.

Stay ahead of the competition by leveraging key insights and evolving trends in the TRUSELTIQ Market @ TRUSELTIQ Market Outlook and Key Assessment

Key Highlights of the TRUSELTIQ Market Report

  • The report contains forecasted sales evaluation of TRUSELTIQ for Cholangiocarcinoma till 2032.
  • It provides comprehensive coverage of late-stage emerging therapies for Cholangiocarcinoma treatment.
  • The report also features qualitative and quantitative analysis with analysts, as well as KOL views for TRUSELTIQ in Cholangiocarcinoma.

Why TRUSELTIQ Market Report?

  • Leading TRUSELTIQ for Cholangiocarcinoma forecasted market data will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the TRUSELTIQ.
  • A thorough TRUSELTIQ market forecast will help understand how the drug is competing with other emerging therapies in the therapeutics landscape.
  • It will help to get an analysis of the TRUSELTIQ clinical trial advancements and the detailed clinical assessment, regulatory, and commercial assessment
  • The report also provides future market assessments for TRUSELTIQ market for Cholangiocarcinoma in the 7 Major Markets, advanced qualitative analysis like SWOT, expert analysts’ views, a detailed overview of market competitors, and a short analysis of other emerging therapies in Cholangiocarcinoma.

Download the sample report to learn more about the evolving market dynamics @ TRUSELTIQ Market Trends and Key Developments

Related Reports By DelveInsight:

Cholangiocarcinoma Market Outlook and Forecast

“Cholangiocarcinoma Market Insights, Epidemiology and Market Forecast 2032” report delivers an in-depth understanding of Cholangiocarcinoma, historical and forecasted epidemiology as well as the Cholangiocarcinoma market trends in the United States, EU4 (Germany, Spain, Italy, and France), and the United Kingdom, and Japan. It also covers the key companies and emerging therapies in the Cholangiocarcinoma therapeutics landscape.

Top Services Offered By DelveInsight:

Explore success with our case study on R&D, Manufacturing & Commercial Capabilities. Uncover insights for strategic growth in the industry.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/case-study/r-and-d-landscape-assessment

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: QED Therapeutics’ TRUSELTIQ market size expected to increase many folds by 2032, report DelveInsight

GlocalMe Launches Portable Wi-Fi Solutions for 2024 Valentine’s Day

Plano, TX – In the midst of the burgeoning travel season of 2024, GlocalMe seizes the moment to provide an exclusive 20% discount for its portable Wi-Fi devices, a rare opportunity for wanderlust enthusiasts. As the world emerges from the grip of the pandemic, outdoor activities and travel are regaining their popularity, making this Valentine’s Day an ideal time for an escapade.

 

The year 2024 has ushered in a new era of travel enthusiasts seeking adventure, with outdoor activities becoming the focal point of leisure. The post-pandemic world is witnessing a surge in the demand for travel, and GlocalMe stands as a beacon for those embarking on international journeys. Positioned as the only publicly traded company exclusively specializing in portable Wi-Fi for global travelers, GlocalMe ensures strong signals and swift connectivity, establishing itself as the preferred choice for global wanderers.

Key Highlights:

1, Travel Boom in 2024: With the conclusion of the pandemic, outdoor activities are experiencing a resurgence, and travel is regaining its popularity. The current year marks an opportune time for individuals to embark on journeys, creating a favorable environment for companies catering to the travel industry.

2, International Travel Norm: As international travel becomes a commonplace affair, GlocalMe emerges as a leading provider of portable Wi-Fi solutions. With robust signals and rapid connections, GlocalMe positions itself as the sole publicly traded company specializing in portable Wi-Fi devices for global travelers.

GlocalMe Product Features:

GlocalMe’s product line encompasses a range of state-of-the-art Wi-Fi devices, offering users a seamless and reliable connectivity experience. The company’s commitment to excellence has positioned it as a frontrunner in the industry. Key product categories include:

Wi-Fi Hotspot: GlocalMe’s Wi-Fi hotspots ensure a stable and powerful internet connection, catering to the diverse needs of modern-day travelers.

Why Choose GlocalMe?

1, Global Coverage: GlocalMe’s devices provide global coverage, ensuring users stay connected in even the remotest corners of the world.

2, Reliability: As the only publicly traded company specializing in portable Wi-Fi for international travelers, GlocalMe guarantees reliability and performance.

3, Ease of Use: With user-friendly interfaces, GlocalMe’s devices are designed for ease of use, making them accessible to both tech-savvy individuals and those less familiar with technology.

Valentine’s Day Special Offer:

To celebrate the love for exploration, GlocalMe is extending a rare 20% discount on all its products this Valentine’s Day. The promotion is available exclusively through the official GlocalMe website [https://www.glocalme.com]. Embrace the opportunity to enhance your travel experience with reliable connectivity and make this Valentine’s Day a memorable one.

About GlocalMe

GlocalMe is a mobile data connection solution brand under Nasdaq-listed technology company uCloudlink (NASDAQ: UCL), helping users across the world to access mobile internet data more efficiently with a range of their own hardware and software products. They strive for enabling the best user experience on various increased-intensity online services requiring a stable and high-speed data connection. Their innovative technology will allow domestic users and international visitors free from shopping for local SIM cards or the high expenses of roaming data in over 150 countries in the world.

Social Links

Facebook: https://www.facebook.com/Glocalme

Twitter: https://twitter.com/GlocalMeMoments

YouTube: https://www.youtube.com/glocalme

Instagram: https://www.instagram.com/glocalmemoments/

Media Contact
Company Name: GlocalMe
Contact Person:
Email: Send Email
Address:1309 W 15th St STE 260
City: Plano
State: TX 75075
Country: United States
Website: https://www.glocalme.com

Philadelphia Addiction Center Introduces Revolutionary Esperal Implant for Treating Alcoholism

The Philadelphia Addiction Center has introduced the Esperal Implant to deter alcohol consumption through adverse reactions from drinking. Early trials show nearly 100% effectiveness in aiding recovery.

Philadelphia, PA – February 05, 2024 – The Philadelphia Addiction Center today announced the release of the innovative Esperal Implant to treat alcohol addiction. This implant, inserted under the skin in a simple office procedure, deters alcohol consumption by causing an extremely uncomfortable reaction when the patient drinks alcohol. Early clinical trials by the Philadelphia Addiction Center show the implant has a nearly 100% success rate in supporting sobriety. 

“Alcohol addiction wrecks lives, destroys families, and kills people. We’ve seen it too many times,” said Dr. Victor Tsan, Medical Director at the Philadelphia Addiction Center. “The statistics around alcohol abuse are sobering. Nearly 15 million adults have an alcohol use disorder. Heavy drinking is responsible for 140,000 deaths per year in America. And sadly, less than 10% of those who need treatment actually receive it.”

Dr. Tsan continues, “The Esperal Implant gives me tremendous hope that we finally have a foolproof solution to keep patients from drinking. For decades, we’ve struggled to find an effective medical deterrent to help people stay sober once they walk out our doors. This technology is a game changer.” 

The grain-sized Esperal Implant contains a reservoir of Disulfiram, a medication that causes flushing, nausea, vomiting, and other unpleasant symptoms when combined with alcohol. If a patient drinks after receiving the implant, they experience what is called the Disulfiram-Ethanol Reaction (DER) within minutes. 

“Imagine having the worst hangover of your life instantly after taking even a small sip of alcohol. That’s what DER feels like,” explained Dr. Tsan. “Patients tell me going through DER is so awful, they never want to drink again.” 

Studies show that pairing the aversive effects of DER with counseling and support groups helps retrain the brain’s addiction pathways. The implant acts as a powerful motivator to stay sober while patients do deeper personal work to overcome addiction triggers and dependencies. 

Unlike taking oral medication daily, the implant ensures continuous medication delivery round-the-clock and round-the-calendar. Patients can’t simply skip a dose if they want to drink. This constant deterrence is what makes the Esperal Implant revolutionary.

The tiny implant provides steady Disulfiram dosing for 3-5 years until the chip naturally dissolves. The delivery method eliminates patient compliance issues that reduce the efficacy of pills or injections. There are also no ongoing prescriptions, pharmacy runs, or reminders needed – just smooth, continuous medication release inside the body.

The American Society of Addiction Medicine reports that medication-assisted therapy, paired with counseling, improves outcomes over counseling alone. By seamlessly incorporating medical and behavioral treatment, the Esperal Implant thwarts drinking on physical and psychological levels simultaneously.

The outpatient insertion procedure takes only 3-5 minutes using local anesthetic. The tiny incision often heals in just 24 hours with no ongoing pain or scarring. Philadelphia Addiction Center offers an inclusive cost of just $1700 for the premium model containing a Disulfiram and Naltrexone combination, including full addiction screening, counseling about risks and side effects of the implant, one NADA acupuncture session, one hypnotherapy session for addiction, and insertion of the implant. Compared to the high cost of years of repeated relapse, it provides exceptional value.

Kim Taylor, a patient of Dr. Tsan, says, “I struggled with alcohol for 15 years. Rehab programs worked for a while, but I always relapsed. Once I got the Esperal Implant, everything changed. Knowing how sick I’d feel if I drank was the extra push I needed. I’ve been sober almost 2 years now and have my life back again thanks to this implant!”

Dr. Tsan concludes, “For people struggling with alcohol addiction who want to stop drinking but haven’t had success yet, the Esperal Implant could be life-changing. We are one of the first centers to bring this innovative treatment to patients in America. Call us today to find out if it’s right for you or your loved one.”

The Philadelphia Addiction Center provides comprehensive care programs for people fighting alcohol and opioid addiction. Treatment options include counseling, support groups, detoxification, the Esperal Implant, and other medication-assisted therapies. Call (267) 403-3085 or visit PhilaAddictionCenter.com to learn more.

About Philadelphia Addiction Center:

Led by Medical Director Dr. Victor Tsan, The Philadelphia Addiction Center boasts a multidisciplinary team that includes addiction counselors, clinicians, social workers, and peer support specialists, offering comprehensive treatment for alcohol use disorder and opioid addictions. Our evidence-based programs combine counseling, peer groups, detox services, and groundbreaking technologies like the Esperal Implant. We craft customized treatment plans that set patients up for long-term success in overcoming addictions. Our non-judgmental environment helps patients heal their mind, body, and spirit. If you or a loved one is struggling with addiction, contact us today to discuss treatment options.

Philadelphia Addiction Center, Dr. Victor Tsan info@philaaddictioncenter.com

https://philaaddictioncenter.com/esperal-implant-for-alcoholism/

Media Contact
Company Name: Philadelphia Addiction Center
Contact Person: Dr. Victor Tsan
Email: Send Email
Country: United States
Website: https://philaaddictioncenter.com/esperal-implant-for-alcoholism/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Philadelphia Addiction Center Introduces Revolutionary Esperal Implant for Treating Alcoholism

EV Connector Market worth $10.9 billion by 2030, at a CAGR of 27.1%

“EV Connector Market Size”
EV Connector Market by System Type (Sealed, Unsealed), Application (ADAS and Safety, Battery Management System, Body Control and Interiors), Propulsion (BEV, PHEV, FCEV), Voltage, Connection Type, Component and Region – Global Forecast to 2030

The global EV connector market is projected to grow from USD 2.0 billion in 2023 to USD 10.9 billion by 2030, registering a CAGR of 27.1%.

EV connectors for high-voltage systems and need of miniaturization, weight reduction, and high-performance materials, and a surge in data transmission and complex systems for ADAS, battery management, vehicle lighting and autonomous driving, demanding high-bandwidth and low-latency EV connectors. Electric vehicles (EVs) are rapidly using advanced driver-assistance systems (ADAS) and autonomous driving technologies, which require connectors to handle the massive data flow. This gives connector manufacturers even more chances to advance technologically and meet the constantly changing demands of the electric revolution.

“Engine management and powertrain application is expected to show a significant growth rate during the forecast period.”

The engine management and power train segment is projected to register a CAGR of 24.3% during the forecast period. The engine management system in a PHEV is responsible for controlling the operation of the engine, including the ignition, fuel injection, and emissions control systems. The engine management system also coordinates the engine’s operation with the electric motor and battery to provide optimal performance and efficiency. The powertrain in a PHEV typically consists of an internal combustion engine (ICE), an electric motor, and a battery. The ICE and electric motor are connected to the transmission, which drives the wheels. A PHEV’s engine management system and powertrain are designed to work together to provide optimal performance and efficiency. High-voltage battery connectors transmit high-voltage DC power from the battery pack to the electric motor and other high-voltage components. Fuel injector and spark plug Connectors deliver fuel and ignition signals to the engine cylinders, ensuring proper combustion. ECU connectors transmit data from various engine sensors to the ECU, allowing it to monitor and control engine performance. Power Control Unit (PCU) connectors transmit data from the electric motor and battery to the PCU, allowing it to manage the electric powertrain system.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=59111615

“Board – to – Board connection system to hold largest market share during the forecast period.”

Board-to-board connectors play a critical role in high-end applications within electric vehicles (EVs), contributing to advanced electronic systems’ overall performance, reliability, and functionality. In high-end EV applications, these connectors are essential for high-speed data transmission, battery management systems for high-capacity batteries, complex sensor networks for autonomous driving, high-resolution displays, infotainment systems and others. Board-to-board connectors dominate within electronic modules due to their compact size and ease of integration. The trend is towards miniaturization and increased integration, which could lead to higher adoption of board-to-board connectors in near future.  Also the inclination of users toward high-tech applications OEMs are offering advanced applications such as human machine interface (HMI), airbag control, adaptive cruise control, and auto-park assist, which creates the demand for connectors to be used in new automotive systems. OEMs such as BMW (Germany), Audi (Germany), Mercedes-Benz (Germany), and Volkswagen AG (Germany) offer this high-end application in their vehicle models such as BMW iX, Audi e-tron GT, Mercedes-Benz EQC and Volkswagen ID.4 among others. All such high end application require to be connected by board – to – board connection. Thus, growing demand for high-end applications is estimated to drive the EV connector market. With the changing demands of passengers and OEMs, new and advanced applications are expected to penetrate the market.

“North America will be the prominent growing market for EV connectors during the forecast period.”

North America is a regional hub for many renowned OEMs delivering quality, high-performance vehicles. In North America, OEMs like Tesla and GM focus on developing cleaner, faster, and high-performance electric vehicles. Nissan, BMW, Volkswagen, and Daimler are the leading OEMs in the US that have launched electric vehicles in the region. The top-selling electric vehicles in the US are Chevy Volt, Tesla Model S, Nissan Leaf, and Ford Fusion Energy PHEV. Along with OEMS, EV connector manufacturers such as TE Connectivity (Switzerland), Amphenol (US), Samtec (US), and Huber+Suhner (Switzerland), among others, are present in the Region. Various services offered by electric vehicle infrastructure providers have increased the adoption rate of electric vehicles in US. Tesla, Ford Motors, and General Motors have included some ADAS features as standard in their EVs. For instance, Tesla Model 3 & Model Y offer ADAS features such as adaptive cruise control, lane centering, and automatic lane changes. Additionally, in July 2022, Cadillac Lyriq a luxurious SUV by General Motors was launched with super cruise system, which allows hands-free driving on mapped highways. It also features a high-resolution, curved OLED display spanning the instrument cluster and infotainment system for an immersive driving experience. The EV connector market growth in North America is expected to be significant due to the rise in EV sales and connectivity-based applications, including autonomous driving, connected services, ADAS, high-end infotainment, and powertrain solutions. As technology becomes more widely available and affordable, more consumers in this region purchase vehicles with ADAS features. This has led to a rise in demand for these systems and an increase in the number of electric vehicles equipped with ADAS. Thus, the demand for EV connectors will also increase with the rising sales of EVs, increased adaptation of ADAS, high-end infotainment, and powertrain solutions.

Key Market Players

The EV connector market is dominated by established players such as TE Connectivity Ltd. (Switzerland), Aptiv PLC (Ireland), Yazaki Corporation (Japan), Molex LLC (US), and Sumitomo Electric Industries Ltd. (Japan).

Request Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=59111615

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/ev-connector-market-59111615.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: EV Connector Market worth $10.9 billion by 2030, at a CAGR of 27.1%